TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33256614

Group type: EXPERIMENTAL
Intervention: Low-volume leg resistance training (RT)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Moderate-volume leg resistance training (RT)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Traditional normalization and non-normalized models
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Overall training effect
Number of subjects: 25
Study: 35564491

Group type: EXPERIMENTAL
Intervention: Pre-MetS
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Pre-MetS (low sleep satisfaction)
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: MetS (low sleep satisfaction)
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: BMI (low sleep satisfaction)
Number of subjects: 167

Group type: COMPARATOR
Intervention: High sleep satisfaction
Number of subjects: 167
Study: 33067067

Group type: EXPERIMENTAL
Intervention: Prediction model including predictors: male gender, respiratory rate≦10 cycles/min, heart rate <60 or ≧120 beats/min, systolic blood pressure <100 mmHg, level of consciousness, oxygen saturation <94%.
Number of subjects: 252771
Study: 34617960

Group type: EXPERIMENTAL
Intervention: Phenylephrine 2.5%
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (fellow eye)
Number of subjects: 20
Study: 33387427

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemoradiotherapy (NCRT) with polychemotherapy (cisplatin and paclitaxel) followed by radiotherapy in 25 patients.
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemoradiotherapy (NCRT) with chemoradiomodification (paclitaxel and carboplatin) in 30 patients.
Number of subjects: 75

Group type: COMPARATOR
Intervention: Radiation therapy only in 20 patients (comparison group).
Number of subjects: 75
Study: 36098967

Group type: EXPERIMENTAL
Intervention: In-person training intervention
Number of subjects: 2892

Group type: EXPERIMENTAL
Intervention: Full-tech intervention with in-person training
Number of subjects: 2892

Group type: EXPERIMENTAL
Intervention: Full-tech intervention
Number of subjects: 2892
Study: 34600559

Group type: EXPERIMENTAL
Intervention: Forced expiratory technique and sputum induction
Number of subjects: 280

Group type: COMPARATOR
Intervention: Tracheal suction
Number of subjects: 280
Study: 32576351

Group type: EXPERIMENTAL
Intervention: Noninvasive ventilation based on APACHE II score (ventilation initiated when score > 10, weaned when score ≤ 10)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Routine nursing in ICU with standard mechanical ventilation timing
Number of subjects: 106
Study: 35380178

Group type: EXPERIMENTAL
Intervention: Lenvatinib responders
Number of subjects: 261

Group type: EXPERIMENTAL
Intervention: Lenvatinib nonresponders
Number of subjects: 261

Group type: EXPERIMENTAL
Intervention: Lenvatinib with low tumor burden (≤40 mm)
Number of subjects: 261

Group type: EXPERIMENTAL
Intervention: Lenvatinib with high tumor burden (>40 mm)
Number of subjects: 261

Group type: EXPERIMENTAL
Intervention: Baseline tumor burden
Number of subjects: 261
Study: 32998921

Group type: EXPERIMENTAL
Intervention: Dance and standard rehabilitation
Number of subjects: 48

Group type: COMPARATOR
Intervention: Standard rehabilitation
Number of subjects: 48
Study: 33361164

Group type: EXPERIMENTAL
Intervention: C-reactive protein (CRP) point of care testing with additional healthcare worker guidance
Number of subjects: 24960

Group type: COMPARATOR
Intervention: Routine care (control group)
Number of subjects: 24960
Study: 35398912

Group type: EXPERIMENTAL
Intervention: Integrative neuromuscular training (EG) for 13 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Normal lifestyle (CG)
Number of subjects: 50
Study: 34842993

Group type: EXPERIMENTAL
Intervention: CGFs combined with deproteinized bovine bone mineral (DBBM) and covered with CGFs membrane (CGFs/DBBM group)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: DBBM alone and covered with collagen membrane (DBBM group)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group spontaneous healing
Number of subjects: 36
Study: 34399434

Group type: EXPERIMENTAL
Intervention: Mid-trimester serum proteomics screening and risk-reduction protocol
Number of subjects: 1191

Group type: COMPARATOR
Intervention: Standard care (unscreened women)
Number of subjects: 1191

Group type: EXPERIMENTAL
Intervention: Mid-trimester serum proteomics screening
Number of subjects: 1191
Study: 32851902

Group type: EXPERIMENTAL
Intervention: Fascial and vaginal epithelial plication (FEP)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Standard posterior colporrhaphy (SPC)
Number of subjects: 22
Study: 32948554

Group type: EXPERIMENTAL
Intervention: 500 mL of intravenous crystalloid
Number of subjects: 1065

Group type: COMPARATOR
Intervention: No intravenous fluid bolus
Number of subjects: 1065
Study: 35276967

Group type: EXPERIMENTAL
Intervention: Rice bran supplementation (1–5 g/day for 6 months)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Rice bran supplementation
Number of subjects: 50

Group type: COMPARATOR
Intervention: Non-intervention control group
Number of subjects: 50
Study: 34221941

Group type: EXPERIMENTAL
Intervention: Sitting position spinal anesthesia
Number of subjects: 106

Group type: COMPARATOR
Intervention: Lateral position spinal anesthesia
Number of subjects: 106
Study: 33434519

Group type: EXPERIMENTAL
Intervention: Modified tooth sectioning method
Number of subjects: 300

Group type: COMPARATOR
Intervention: Conventional method
Number of subjects: 300
Study: 32180155

Group type: EXPERIMENTAL
Intervention: BoNT‐A injection into the pectoralis major and teres major muscles
Number of subjects: 60

Group type: COMPARATOR
Intervention: Suprascapular nerve block (SSNB)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Comparison between BoNT‐A and SSNB
Number of subjects: 60
Study: 33545163

Group type: EXPERIMENTAL
Intervention: Selexipag
Number of subjects: 1156

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1156
Study: 35512064

Group type: EXPERIMENTAL
Intervention: Integrated care combined with vasopressin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional care combined with vasopressin
Number of subjects: 0
Study: 34139859

Group type: EXPERIMENTAL
Intervention: Apolipoprotein B (ApoB) lowering
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Apolipoprotein(a)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Extra-small very-low-density lipoprotein particle concentration
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Large low-density lipoprotein particle concentration
Number of subjects: 0
Study: 35533737

Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Training (IMT) + Aerobic Exercise
Number of subjects: 40

Group type: COMPARATOR
Intervention: Aerobic Exercise
Number of subjects: 40
Study: 33401219

Group type: EXPERIMENTAL
Intervention: Atorvastatin (ATORVA) 40 mg daily for 6 months
Number of subjects: 160

Group type: COMPARATOR
Intervention: Rosuvastatin (ROSUVA) 10 mg daily for 6 months
Number of subjects: 160
Study: 32134758

Group type: EXPERIMENTAL
Intervention: Intracoronary Adenosine (two bolus doses)
Number of subjects: 104

Group type: COMPARATOR
Intervention: IC normal saline (placebo group)
Number of subjects: 104
Study: 34368971

Group type: EXPERIMENTAL
Intervention: Three-step irradiance schedule
Number of subjects: 90

Group type: COMPARATOR
Intervention: Two-step irradiance schedule
Number of subjects: 90

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 90
Study: 34656378

Group type: EXPERIMENTAL
Intervention: PCV13-MDV
Number of subjects: 0

Group type: COMPARATOR
Intervention: PCV13-PFS
Number of subjects: 0
Study: 36960162

Group type: EXPERIMENTAL
Intervention: Interferon beta-1b and lopinavir-ritonavir
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 62
Study: 33647972

Group type: EXPERIMENTAL
Intervention: Proton radiotherapy (PT)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Intensity-modulated radiotherapy (IMRT)
Number of subjects: 90
Study: 32907617

Group type: COMPARATOR
Intervention: Sarilumab 150 mg vs. placebo
Number of subjects: 2112

Group type: COMPARATOR
Intervention: Sarilumab 200 mg vs. placebo
Number of subjects: 2112

Group type: COMPARATOR
Intervention: Sarilumab 200 mg vs. adalimumab 40 mg
Number of subjects: 2112
Study: 37145935

Group type: EXPERIMENTAL
Intervention: Videolaryngoscope with a non‐channelled Macintosh blade
Number of subjects: 330

Group type: COMPARATOR
Intervention: Flexible fibrescope
Number of subjects: 330
Study: 33982623

Group type: EXPERIMENTAL
Intervention: Erenumab
Number of subjects: 648

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 648
Study: 35435159

Group type: EXPERIMENTAL
Intervention: Combined application of palpebral margin cleaning with cotton pads and levofloxacin eye drops for three days before surgery
Number of subjects: 61

Group type: COMPARATOR
Intervention: Levofloxacin eye drops alone for three consecutive days
Number of subjects: 61
Study: 34030910

Group type: EXPERIMENTAL
Intervention: Medical screen group (N = 40)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Computer group (N = 40)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (N = 40)
Number of subjects: 120
Study: 32872348

Group type: EXPERIMENTAL
Intervention: Balanced Plate Intervention
Number of subjects: 0
Study: 35139918

Group type: EXPERIMENTAL
Intervention: Diet intervention (DIET) - 1 hour per week of group-based dietary counseling including education, goal setting, and strategy training.
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control education (ED) - 1 hour per week of group-based brain health education classes.
Number of subjects: 14
Study: 33410885

Group type: EXPERIMENTAL
Intervention: Osimertinib plus Bevacizumab
Number of subjects: 87

Group type: COMPARATOR
Intervention: Osimertinib alone
Number of subjects: 87
Study: 33976369

Group type: EXPERIMENTAL
Intervention: Dynamic web-based decision aid
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 32295779

Group type: EXPERIMENTAL
Intervention: Exercise therapy
Number of subjects: 480

Group type: COMPARATOR
Intervention: Psychotherapy as treatment as usual
Number of subjects: 480
Study: 35717531

Group type: EXPERIMENTAL
Intervention: Video training
Number of subjects: 18

Group type: COMPARATOR
Intervention: No-video training
Number of subjects: 18
Study: 32305573

Group type: EXPERIMENTAL
Intervention: Electroacupuncture trigeminal nerve stimulation plus body acupuncture (EA/TNS + BA)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Minimum acupuncture stimulation (MAS)
Number of subjects: 93
Study: 33158702

Group type: EXPERIMENTAL
Intervention: MRI examination with acoustic noise reduction
Number of subjects: 174

Group type: COMPARATOR
Intervention: Standard MRI examination
Number of subjects: 174
Study: 34569538

Group type: EXPERIMENTAL
Intervention: CMV‐HyperIg treatment upon seroconversion
Number of subjects: 9535

Group type: COMPARATOR
Intervention: Routine prenatal care with CMV‐serostatus testing at end of pregnancy (control)
Number of subjects: 9535
Study: 36415489

Group type: EXPERIMENTAL
Intervention: Clomiphene citrate and Coenzyme Q10
Number of subjects: 149

Group type: COMPARATOR
Intervention: Clomiphene citrate only
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Clomiphene citrate and Coenzyme Q10 (non-obese women)
Number of subjects: 149

Group type: COMPARATOR
Intervention: Clomiphene citrate only (obese women)
Number of subjects: 149
Study: 32272389

Group type: EXPERIMENTAL
Intervention: Roommates who desisted from using marijuana (used before college but stopped in college)
Number of subjects: 1953

Group type: COMPARATOR
Intervention: Roommates who never used marijuana, always used, or started using after entering college
Number of subjects: 1953

Group type: COMPARATOR
Intervention: Respondents who did not use marijuana before college
Number of subjects: 1953
Study: 36263875

Group type: EXPERIMENTAL
Intervention: Clinic education plus promotora home visits (n = 22)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Clinic education (n = 26)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Promotora group
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 48
Study: 33386901

Group type: EXPERIMENTAL
Intervention: Walking-based intervention (28 sessions over 8 weeks, 2-5 times/week, with 1 supervised session per week by a physiotherapist)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (verbal and written advice on the benefits of exercise)
Number of subjects: 20
Study: 32931691

Group type: EXPERIMENTAL
Intervention: Centralization
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Radialization
Number of subjects: 14
Study: 36217901

Group type: EXPERIMENTAL
Intervention: RP7214 single-dose (100, 200, and 400 mg QD)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: RP7214 multiple doses (200 and 400 mg BID for 7 days)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: RP7214 food effect (single dose of 200 mg)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: RP7214 (general)
Number of subjects: 42
Study: 34193630

Group type: EXPERIMENTAL
Intervention: WhatsApp-based physical activity intervention for children with ASD for 4 weeks
Number of subjects: 14
Study: 35536579

Group type: EXPERIMENTAL
Intervention: Community and clinic education intervention program (Ask About Aspirin campaign)
Number of subjects: 8342
Study: 32058185

Group type: EXPERIMENTAL
Intervention: Surface electrical stimulation (SES) training for 8 weeks
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (no SES training)
Number of subjects: 34
Study: 34133067

Group type: EXPERIMENTAL
Intervention: Distraction plus cryotherapy
Number of subjects: 50

Group type: COMPARATOR
Intervention: Cryotherapy alone
Number of subjects: 50
Study: 36086876

Group type: EXPERIMENTAL
Intervention: Steroid-eluting stents containing mometasone furoate
Number of subjects: 95

Group type: COMPARATOR
Intervention: Control side (no steroid-eluting stents)
Number of subjects: 95
Study: 32622913

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 1875

Group type: EXPERIMENTAL
Intervention: Pre-procedural left ventricular ejection fraction (LVEF)<45%
Number of subjects: 1875

Group type: EXPERIMENTAL
Intervention: eGFR≤30 mL/min/1.73m2 or renal replacement therapy
Number of subjects: 1875
Study: 32951725

Group type: EXPERIMENTAL
Intervention: Laying on of hands with Spiritual connection (LHS)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control - Laying on of hands without Spiritual connection (control-LHW)
Number of subjects: 84
Study: 35457469

Group type: EXPERIMENTAL
Intervention: Speed training
Number of subjects: 20

Group type: COMPARATOR
Intervention: Accuracy training
Number of subjects: 20
Study: 32711121

Group type: EXPERIMENTAL
Intervention: Questionnaire sent with a pen
Number of subjects: 4812

Group type: COMPARATOR
Intervention: Questionnaire resent
Number of subjects: 4812

Group type: EXPERIMENTAL
Intervention: Overall survey participation
Number of subjects: 4812

Group type: EXPERIMENTAL
Intervention: General agreement on quality of care improvement
Number of subjects: 4812
Study: 32245961

Group type: EXPERIMENTAL
Intervention: Self-management education programme for COPD in the context of multi-morbidity, delivered by general practice nurses in face-to-face sessions.
Number of subjects: 0
Study: 35010730

Group type: EXPERIMENTAL
Intervention: HMB supplementation
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo (PLAC)
Number of subjects: 8
Study: 34293643

Group type: EXPERIMENTAL
Intervention: Computer game assisted task specific exercises (CGATSE)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Occupational therapy (OT)
Number of subjects: 30
Study: 35590347

Group type: EXPERIMENTAL
Intervention: Low intensity (once daily) CTAR‐SwiFt exercise
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: High intensity (twice daily) CTAR‐SwiFt exercises
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: CTAR‐SwiFt intervention
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 60
Study: 34271953

Group type: EXPERIMENTAL
Intervention: 500 mg of Astragalus Membranaceus Root (AMR)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 32020485

Group type: EXPERIMENTAL
Intervention: Integrated exercise and health education program (self-directed home-based resistance training for 5 months)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (health education program only)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Integrated exercise and health education program
Number of subjects: 0
Study: 32162497

Group type: EXPERIMENTAL
Intervention: Experimental transdermal gel (ETG)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo gel (PTG)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Complete multimodal treatment (ETG + external therapies, art therapies, neurofunctional reorganization)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Weekly external therapies, art therapies, and neurofunctional reorganization with ETG
Number of subjects: 48
Study: 615270428

Group type: EXPERIMENTAL
Intervention: Treatment of unruptured AVMs grade 1 and 2
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multidisciplinary team evaluation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Treatment strategy defined by multidisciplinary team
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prospective European Multidisciplinary Registry
Number of subjects: 0
Study: 32020565

Group type: EXPERIMENTAL
Intervention: Prolonged-release oxycodone/naloxone (OXN PR)
Number of subjects: 234

Group type: COMPARATOR
Intervention: Prolonged-release oxycodone (OXY PR)
Number of subjects: 234
Study: 33730384

Group type: EXPERIMENTAL
Intervention: CBT4CBT plus treatment as usual (CBT4CBT+TAU)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: CBT4CBT plus brief monitoring (CBT4CBT+monitoring)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 63
Study: 32842839

Group type: EXPERIMENTAL
Intervention: Culturally-adapted treatment (CAT)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Standard evidence-based treatment (EBT)
Number of subjects: 58
Study: 35934663

Group type: EXPERIMENTAL
Intervention: Pelvic Floor Muscle Training (PFMT) for 6 weeks (home exercise program)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group (no treatment for OAB)
Number of subjects: 43
Study: 32776430

Group type: EXPERIMENTAL
Intervention: One cup of espresso coffee per day
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Three cups of espresso coffee per day
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: One cup of espresso coffee plus two CBPCC twice per day
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group not explicitly mentioned
Number of subjects: 21
Study: 32460699

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (DEX) 0.4 μg/kg over 10 mins followed by 0.4 μg/kg/h till the second day morning after surgery
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo (normal saline) administered similarly to DEX group
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (DEX)
Number of subjects: 160
Study: 36027570

Group type: EXPERIMENTAL
Intervention: Dapagliflozin (10 mg once daily)
Number of subjects: 6263

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6263
Study: 32945145

Group type: EXPERIMENTAL
Intervention: Psychological interventions (CBT and CBT + add on treatment)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: More than 20 treatment sessions
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Cognitive behavioural therapy (CBT)
Number of subjects: 61

Group type: COMPARATOR
Intervention: General adolescent help-seeking population (HSP) receiving psychological interventions
Number of subjects: 61
Study: 34907285

Group type: EXPERIMENTAL
Intervention: Flash glucose monitoring (FGM)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Self-monitoring blood glucose (SMBG)
Number of subjects: 146
Study: 32343765

Group type: EXPERIMENTAL
Intervention: Non-diversified diet (NDD) group, n=15, received a 12-week structured dietary intervention.
Number of subjects: 40

Group type: COMPARATOR
Intervention: Diversified diet (DD) control group, n=25, received conventional management.
Number of subjects: 40
Study: 36241081

Group type: EXPERIMENTAL
Intervention: Catch-up Growth
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: Consistently Large
Number of subjects: 235
Study: 32579776

Group type: EXPERIMENTAL
Intervention: JNJ-56136379 (25 mg)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: JNJ-56136379 (75 mg)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: JNJ-56136379 (150 mg)
Number of subjects: 57
Study: 34244316

Group type: EXPERIMENTAL
Intervention: Convalescent plasma plus standard of care (CP+SOC)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 160
Study: 34086631

Group type: EXPERIMENTAL
Intervention: 800-mg orally administered CBD
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 32648983

Group type: EXPERIMENTAL
Intervention: Ketamine mouthwash (4 mg/mL solution; dose 1 mg/kg)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Ketamine mouthwash
Number of subjects: 44

Group type: COMPARATOR
Intervention: Ketamine mouthwash and Placebo
Number of subjects: 44
Study: 34331080

Group type: EXPERIMENTAL
Intervention: Topiramate (up to 200 mg/day)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study: 33374970

Group type: EXPERIMENTAL
Intervention: Low-iron formula (2 mg/L) fortified with bovine lactoferrin (1.0 g/L)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Low-iron formula unfortified with lactoferrin (2 mg/L)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Standard formula with 8 mg of iron/L and no lactoferrin fortification (Control)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Low-iron groups (combined)
Number of subjects: 180
Study: 35633589

Group type: EXPERIMENTAL
Intervention: Hyperchloremia (defined as 110 mmol/L or greater) with two or more occurrences within 48 hours
Number of subjects: 1275

Group type: COMPARATOR
Intervention: Patients without hyperchloremia
Number of subjects: 1275
Study: 33899452

Group type: EXPERIMENTAL
Intervention: High-intensity laser therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fractional radiofrequency therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined methods (high-intensity laser therapy or micro-needling in combination with peels, fillers, PRP injection)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Micro-needling as monotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Microdermabrasion
Number of subjects: 0